R.PR
REGISTERED-PRINCIPAL REGISTER
05/03/2022
Back to search
Official data from USPTO
HARNESSING THE REGENERATIVE POWER OF INFLAMMATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HARNESSING THE REGENERATIVE POWER OF INFLAMMATION
ST13
US500000090604160Class
42
Filing
90604160
Registration
6720358
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
05/03/2022
Trademark type
Word
Nice classes
42
Filing date
03/25/2021
Registration date
05/03/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/03/2022
Last transaction
05/03/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/10/2022
First use in commerce
02/10/2022
Drawing code
4
Owner type
03
Owner location
Tarzana, CA
Examiner
ELTON, DAVID
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CarthroniX, Inc.
Representatives
Gwenn Roos ONSIDECOUNSEL/LAW OFFICE OF GWENN ROOS
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical research; Medical research in the field of infectious diseases; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of inflammationimmunologyregenerationpain management and reductionother neuro- degenerative diseases; Medical and scientific research information in the field of inflammationimmunologyregenerationpain management and reductionother neuro- degenerative diseases; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines; Research and development of vaccines and medicines; Research and development in the field of medicine and pharmaceuticals; Research in the field of inflammationimmunologyregenerationpain management and reductionother neuro- degenerative diseases; Scientific research; Scientific research and development; Scientific research consulting in the field of cosmetics; Scientific research for medical purposes in the field of inflammationimmunologyregenerationpain management and reductionother neuro- degenerative diseases; Scientific consulting and research services relating to foods and dietary supplements; Biochemical research and development; Cell culture services for scientific and research purposesfor others; Genetic testing for scientific research purposes; Pharmaceutical research and development; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research for medical purposes in the area of cancerous diseases
Publications
History of USPTO decisions and trademark events.
19 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/29/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/26/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/24/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/24/2022
IUAF
USE AMENDMENT FILED
02/26/2022
EISU
TEAS STATEMENT OF USE RECEIVED
02/26/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/01/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/07/2021
PUBO
PUBLISHED FOR OPPOSITION
12/07/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/02/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
11/02/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/02/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
11/02/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/02/2021
DOCK
ASSIGNED TO EXAMINER
11/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/01/2021
NWAP
NEW APPLICATION ENTERED
03/29/2021
Continuous trademark protection
Get notified about every new filing that threatens HARNESSING THE REGENERATIVE POWER OF INFLAMMATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.